| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue |
-
| 12,392 | 22,447 | 21,937 | | Cost of Revenue |
-
| 4,845 | 8,966 | 12,832 | | | Gross Profit |
-
| 7,547 | 13,481 | 9,105 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,237 | 11,063 | 17,009 | 13,740 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (4,237) | (3,516) | (3,528) | (4,635) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,797) | 158,684 | (88) | 433 | | Earnings Before Interest And Taxes | (10,861) | 147,722 | (9,129) | (18,429) | | Interest Expense | 728 | 817 | 926 | 965 | | Income Before Tax | (11,589) | 146,905 | (10,055) | (19,394) | | Income Tax Expense |
-
| (14) |
-
|
-
| | Minority Interest | (1,163) |
-
|
-
| 180 | | | | Net Income From Continuing Ops | (11,589) | 146,919 | (10,055) | (19,394) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
| 1,500 |
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,752) | 146,919 | (8,555) | (19,394) | | Preferred Stock And Other Adjustments | 1,163 | (292) | (871) |
-
| | | Net Income Applicable To Common Shares | ($11,589) | $146,627 | ($9,426) | ($19,394) |
|
0.31% Nasdaq 
0.05%
Income Statement
